Published in Br J Pharmacol on February 01, 2006
Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol (2008) 1.78
Cargo-mediated regulation of a rapid Rab4-dependent recycling pathway. Mol Biol Cell (2009) 1.53
Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol (2011) 1.40
Processive phosphorylation: mechanism and biological importance. Cell Signal (2007) 1.31
Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling. J Gen Physiol (2008) 1.08
Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes. J Biol Chem (2009) 1.04
Cyclic AMP signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth (2007) 0.95
Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation. J Biol Chem (2011) 0.93
Desensitization, trafficking, and resensitization of the pituitary thyrotropin-releasing hormone receptor. Front Neurosci (2012) 0.91
ADP-ribosylation factor 6 modulates adrenergic stimulated lipolysis in adipocytes. Am J Physiol Cell Physiol (2010) 0.89
Importance of regions outside the cytoplasmic tail of G-protein-coupled receptors for phosphorylation and dephosphorylation. Biochem J (2010) 0.88
Quantitative modeling of GRK-mediated beta2AR regulation. PLoS Comput Biol (2010) 0.88
Reprogramming of G protein-coupled receptor recycling and signaling by a kinase switch. Proc Natl Acad Sci U S A (2013) 0.87
Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization. Cell Cycle (2011) 0.86
The subtleties of µ-opioid receptor phosphorylation. Br J Pharmacol (2011) 0.82
Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor. J Biol Chem (2014) 0.80
EFR3s are palmitoylated plasma membrane proteins that control responsiveness to G-protein-coupled receptors. J Cell Sci (2014) 0.80
G-protein-coupled receptor dephosphorylation at the cell surface. Br J Pharmacol (2006) 0.78
G-protein coupled receptor resensitization-appreciating the balancing act of receptor function. Curr Mol Pharmacol (2012) 0.78
Mutating the dileucine motif of the human beta(2)-adrenoceptor reduces the high initial rate of receptor phosphorylation by GRK without affecting postendocytic sorting. Eur J Pharmacol (2010) 0.75
Subcellular trafficking of the TRH receptor: effect of phosphorylation. Mol Endocrinol (2009) 0.75
The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol (1994) 11.55
Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol (1989) 6.76
Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature (1996) 6.32
beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science (1990) 4.53
Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A (1996) 3.57
The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A (1999) 3.43
Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci U S A (1986) 3.38
Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem (1992) 2.91
Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem (1990) 2.42
AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol (2002) 2.26
Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem (1993) 2.13
Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J Cell Biol (1985) 2.08
Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol (1995) 1.93
Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol (2000) 1.90
The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem (1997) 1.86
CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem (1983) 1.85
Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol (2004) 1.79
Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem (1999) 1.60
A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem (1997) 1.59
Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J Biol Chem (2003) 1.58
Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem (2001) 1.55
Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic complexes. J Biol Chem (1999) 1.53
G protein-coupled receptor/arrestin3 modulation of the endocytic machinery. J Cell Biol (2002) 1.53
Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem (2005) 1.50
Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor. EMBO J (2003) 1.43
Rab11 regulates the recycling and lysosome targeting of beta2-adrenergic receptors. J Cell Sci (2004) 1.38
Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. J Biol Chem (1999) 1.28
Gravin-mediated formation of signaling complexes in beta 2-adrenergic receptor desensitization and resensitization. J Biol Chem (2000) 1.28
Regulation of rhodopsin dephosphorylation by arrestin. J Biol Chem (1989) 1.27
The role of phosphorylation/dephosphorylation in agonist-induced desensitization of D1 dopamine receptor function: evidence for a novel pathway for receptor dephosphorylation. Mol Pharmacol (2001) 1.17
Agonist-induced sorting of human beta2-adrenergic receptors to lysosomes during downregulation. J Cell Sci (1999) 1.17
Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution. Mol Pharmacol (1996) 1.13
Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme. J Biol Chem (2001) 1.08
Lysosome proteins are redistributed during expression of a GTP-hydrolysis-defective rab5a. J Cell Sci (2001) 1.07
Ligand-stimulated beta 2-adrenergic receptor internalization via the constitutive endocytic pathway into rab5-containing endosomes. J Cell Sci (1995) 1.06
cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. J Biol Chem (1994) 1.05
N-formyl peptide receptors cluster in an active raft-associated state prior to phosphorylation. J Biol Chem (2004) 1.01
Light-driven translocation of the protein phosphatase 2A complex regulates light/dark dephosphorylation of phosducin and rhodopsin. Biochemistry (2002) 0.92
Regulation of macropinocytosis in v-Src-transformed fibroblasts: cyclic AMP selectively promotes regurgitation of macropinosomes. J Cell Sci (1998) 0.91
Endosome sorting of beta 2-adrenoceptors is GRK5 independent. Br J Pharmacol (2003) 0.88
Specific changes in beta2-adrenoceptor trafficking kinetics and intracellular sorting during downregulation. Eur J Pharmacol (1999) 0.84
Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol (2007) 2.24
Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A (2004) 1.85
Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol (2004) 1.79
β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model. Am J Respir Cell Mol Biol (2012) 1.73
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A (2009) 1.53
Rab11 regulates the recycling and lysosome targeting of beta2-adrenergic receptors. J Cell Sci (2004) 1.38
Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation. J Biol Chem (2006) 1.33
Dramatic difference in diversity between Plasmodium falciparum and Plasmodium vivax reticulocyte binding-like genes. Am J Trop Med Hyg (2005) 1.33
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther (2007) 1.30
JAM2 interacts with alpha4beta1. Facilitation by JAM3. J Biol Chem (2002) 1.24
Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. Mol Cell Biol (2008) 1.23
Beta(2)-adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for G(s)/G(i) switching. Mol Pharmacol (2002) 1.14
Characterization of beta2-adrenergic receptor dephosphorylation: Comparison with the rate of resensitization. Mol Pharmacol (2006) 1.13
Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010. Emerg Infect Dis (2013) 1.08
Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling. J Gen Physiol (2008) 1.08
Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol (2006) 1.06
Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation. Mol Pharmacol (2009) 1.05
Phosphorylation of the beta2-adrenergic receptor in plasma membranes by intrinsic GRK5. Biochemistry (2007) 1.05
Human health and performance for long-duration spaceflight. Aviat Space Environ Med (2008) 1.01
Rapid recycling of beta-adrenergic receptors is dependent on the actin cytoskeleton and myosin Vb. Traffic (2008) 0.98
Delayed mechanism for induction of gamma-glutamylcysteine synthetase heavy subunit mRNA stability by oxidative stress involving p38 mitogen-activated protein kinase signaling. J Biol Chem (2005) 0.91
Regulation of G-protein-coupled receptor activity by rab GTPases. Receptors Channels (2002) 0.91
Accelerated dephosphorylation of the beta2-adrenergic receptor by mutation of the C-terminal lysines: effects on ubiquitination, intracellular trafficking, and degradation. Biochemistry (2008) 0.90
Beta 2 adrenergic receptor 5' haplotypes influence promoter activity. Br J Pharmacol (2002) 0.89
Endosome sorting of beta 2-adrenoceptors is GRK5 independent. Br J Pharmacol (2003) 0.88
Quantitative modeling of GRK-mediated beta2AR regulation. PLoS Comput Biol (2010) 0.88
In vivo phosphorylation of the somatostatin 2A receptor in human tumors. J Clin Endocrinol Metab (2003) 0.88
Two functional reticulocyte binding-like (RBL) invasion ligands of zoonotic Plasmodium knowlesi exhibit differential adhesion to monkey and human erythrocytes. Malar J (2012) 0.87
Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens (2005) 0.87
Methicillin-resistant Staphylococcus aureus resistance to non-beta-lactam antimicrobials in the United States from 1996 to 2008. Diagn Microbiol Infect Dis (2010) 0.87
When informed consent goes poorly: a descriptive study of medical negligence claims and patient complaints. Med J Aust (2011) 0.84
Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins. Biochem J (2007) 0.84
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Int J Antimicrob Agents (2011) 0.83
Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity. J Clin Invest (2013) 0.83
Escherichia coli antimicrobial resistance increased faster among geriatric outpatients compared with adult outpatients in the USA, 2000-10. J Antimicrob Chemother (2013) 0.82
A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testing. Infect Control Hosp Epidemiol (2013) 0.82
Measurement of receptor desensitization and internalization in intact cells. Methods Enzymol (2002) 0.81
Legal disputes over informed consent for cosmetic procedures: a descriptive study of negligence claims and complaints in Australia. J Plast Reconstr Aesthet Surg (2012) 0.80
Legal disputes over duties to disclose treatment risks to patients: a review of negligence claims and complaints in Australia. PLoS Med (2012) 0.79
Marinobufagenin interferes with the function of the mineralocorticoid receptor. Biochem Biophys Res Commun (2007) 0.78
Identification of acid-fast bacilli using pyrosequencing analysis. Diagn Microbiol Infect Dis (2010) 0.78
Inhibitors of phosphoinositide 3-kinase cause defects in the postendocytic sorting of beta2-adrenergic receptors. Exp Cell Res (2007) 0.78
Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory. Diagn Microbiol Infect Dis (2011) 0.78
Mutating the dileucine motif of the human beta(2)-adrenoceptor reduces the high initial rate of receptor phosphorylation by GRK without affecting postendocytic sorting. Eur J Pharmacol (2010) 0.75
What's in a name? J Clin Anesth (2009) 0.75
Rhesus, King of Thrace and erythroblastosis fetalis. Int J Obstet Anesth (2003) 0.75
The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Statins in Asthma: A Closer Look into the Pharmacological Mechanism of Action. Pharmacology (2016) 0.75